Chemo-cytokines network is main target for control of Allergic asthma
DOI:
https://doi.org/10.29328/journal.aaai.1001009References
Athari SS, Pourpak Z, Folkerts G, Garssen J, Moin M, et al. Conjugated Alpha-Alumina nanoparticle with vasoactive intestinal peptide as a Nano-drug in treatment of allergic asthma in mice. Eur J Pharmacol. 2016; 791: 811-820. Ref.: https://goo.gl/gWvMKn
Conroy DM, Williams TJ. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res. 2001; 2: 150-156. Ref.: https://goo.gl/njPKd2
Farjadian S, Moghtaderi M, Kalani M, Gholami T, Hosseini Teshnizi S. Effects of omega-3 fatty acids on serum levels of T-helper cytokines in children with asthma. Cytokine. 2016; 85: 61-66. Ref.: https://goo.gl/LDMXkk
Schuh JM, Blease K, Kunkel SL, Hogaboam CM. Chemokines and cytokines: axis and allies in asthma and allergy. Cytokine Growth Factor Rev. 2003; 14: 503-510. Ref.: https://goo.gl/RYLy4q
Ravensberg AJ, Ricciardolo FL, van Schadewijk A, Rabe KF, Sterk PJ, et al. Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge. J Allergy Clin Immunol. 2005; 115: 779-785. Ref.: https://goo.gl/oPK7PY
Published
How to Cite
License
Copyright (c) 2018 Athari SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This work is licensed under a Creative Commons Attribution 4.0 International License.